Phase II Study of Campath-1H (NSC #950010) and Peripheral Blood Stem Cell Transplant [PBSCT] for Patients With Chronic Lymphocytic Leukemia
Phase of Trial: Phase II
Latest Information Update: 18 May 2018
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 02 Feb 2010 Actual end date (Dec 2004) added as reported by ClinicalTrials.gov.
- 25 Oct 2007 Status changed from in progress to completed.
- 14 Nov 2005 New trial record.